Dr Thomas is VP of Clinical Programs and Operations at Zelira Therapeutics and holds a PhD in experimental and regenerative neuroscience. Meghan has developed a unique experience that spans academic research, public health service strategy and planning, and research ethics and governance and has a proven track record in leading and managing research programs in a large and complex organisation. Her experience ideally positions her to oversee Zelira’s R&D pre-clinical programs and clinical trials.

At Zelira, Dr Thomas also oversees commercial manufacturing operations, regulatory affairs requirements and contributes to Zelira’s substantial patent portfolio. Meghan has been instrumental in launching three medicinal cannabis products with attached clinical data for Australian patients.

Meghan is on the AusBiotech WA State Committee and is part of the Medicinal Cannabis Industry Australia (MCIA) Research Working Group and MCIA Standards Working Group.

Start typing and press Enter to search

Shopping Cart